Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints Rob Gallo as head of corporate communications, Europe and Canada

Will lead efforts to combine communications efforts in two regions

Rob Gallo - TakedaJapan-based Takeda Pharmaceuticals has promoted its interim head of corporate communications for Europe Rob Gallo to a permanent role that also covers Canada.

Gallo had been in his interim position since 2010, overseeing Europe-wide media campaigns, and will now be based at Takeda's regional headquarters in Zurich, Switzerland.

His new responsibilities will include unifying local communication teams as Takeda prepares to combine its Canadian and European businesses into a single Takeda subsidiary, ensuring communication aligns to the company's new strategic model as well as preparing teams for the launch of several products.

Gallo said: “I am delighted to be joining Takeda permanently to help deliver corporate objectives in what is a very exciting stage of the company's development.”

Before joining Takeda, Gallo was a director of Operandi Partners, a corporate communications and issues management consultancy based in London. 

In addition to his pharmaceutical experience, he has also held senior communications posts across a range of FMCG companies in the UK, Italy and Australia.

13th July 2012

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Toast TV

Toast TV are experts in communicating the needs of our clients through engaging and beautifully crafted live action and animated...

Latest intelligence

BL_Where_Now_20140721_CoverImage.jpg
3 Steps to Navigating Multichannel in Healthcare
You know about multichannel, but... where now? Download the 3 Steps to Navigating Multichannel in Healthcare ebook to learn what you should do next when planning your multichannel campaign....
Online Physician Communities
How can pharma develop a more customer-centric approach?
Business pressures and customer needs will force pharma to focus on multichannel marketing in the next few years...
Exploring MINT: Part 2 - Indonesia
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...